Themes
Business
Talent
At the park
Communities
Jobs & internships
Events
News
Contact
Toxys Awarded £1M for Phase 2 of CrossDART CRACK IT Challenge
Advancing Multi-Species In Vitro Assays During phase 2, Toxys will continue to develop and refine multi-species (human, rat, and rabbit) in vitro assays to predict in vivo teratogenicity. The team will qualify these assays using positive and negative reference...
Pharming Group Nominates Fabrice Chouraqui as New CEO
Pharming Group has nominated Fabrice Chouraqui as the successor to CEO Sijmen de Vries. His appointment will be subject to approval at an Extraordinary General Meeting of Shareholders (EGM). Upon his appointment, Chouraqui will join the Board of Directors, while De...
Toxys and Unilever to explore and develop new approach methods (NAMs) for cellular stress
Toxys and Unilever have joined forces to advance New Approach Methodologies (NAMs) for assessing cellular stress—an essential factor in Next Generation Risk Assessment (NGRA). This collaboration aims to refine non-animal testing approaches by validating ToxProfiler,...